We have identified oncogene-responsive sequences in the human c-fos promoter that mediate induction of transcription by several nonnuclear oncoproteins and the tumor promoter TPA. These sequences are regulated in a cell-specific manner. (i) In NIH 3T3 cells, the CArG box of the c-fos promoter is sufficient to mediate activation by oncogenes. (ii) In contrast, in HeLa cells, additional flanking sequences are also required, including the outer arm of the serum response element and the FAP site. We also show that the serum response factor, which binds to the CArG box, activates transcription in vivo in NIH 3T3 cells but not in HeLa cells. Finally, we present evidence that the intracellular level of the c-Fos protein could be a major determinant of cell-specific regulation of these oncogene-responsive elements of the c-fos promoter.
We have identified oncogene-responsive sequences in the human c-fos promoter that mediate induction of transcription by several nonnuclear oncoproteins and the tumor promoter TPA. These sequences are regulated in a cell-specific manner. (i) In NIH 3T3 cells, the CArG box of the c-fos promoter is sufficient to mediate activation by oncogenes. (ii) In contrast, in HeLa cells, additional flanking sequences are also required, including the outer arm of the serum response element and the FAP site. We also show that the serum response factor, which binds to the CArG box, activates transcription in vivo in NIH 3T3 cells but not in HeLa cells. Finally, we present evidence that the intracellular level of the c-Fos protein could be a major determinant of cell-specific regulation of these oncogene-responsive elements of the c-fos promoter.
The c-fos proto-oncogene is the best-characterized member of the early-response genes. Its transcription is induced rapidly, albeit transiently, by serum components, growth factors, and a number of oncogenes (15, 27, 29, 31, 34) . A key role in its regulation is played by the serum response element (SRE), which binds several different proteins (reviewed in references 24 and 34; see Fig. 1A ). The inner core, or CArG box, binds the serum response factor (SRF) (23, 33) . Mutations in the CArG box that abolish SRF binding eliminate induction by serum, 12-0-tetradecanoylphorbol-13-acetate (TPA), and several growth factors in different cell lines (5, 6, 10, 30, 32) . Although this sequence has been found to be necessary and sufficient for induction (25) , there is evidence that other factors are also involved. Mutations in the outer arm of the SRE that prevent binding of the factor p62TCF impair serum and TPA inducibility (8, 29) . The fos gene is also negatively regulated by its own product through the CArG box (7, 17-19, 25, 28 ).
An APl-like site (FAP), located a few nucleotides downstream from the SRE, is also serum responsive. It binds members of the AP1 and CREB families, but only in the absence of SRF because of steric hindrance (5, 35 The SRE is divided into the CArG box, which binds the SRF, and the outer arm, which binds p62TCF (when complexed to SRF). FAP binds members of the AP1 and CREB families. Other factors that interact with the fos promoter are represented between brackets and below their binding sequences (PEA3 [11] ; MAPF1 and MAPF2 [26, 36] Transfections. Transfections were performed as follows. (i) For LMTK-cells, subconfluent 9-cm-diameter plates were incubated for 30 to 60 min with DEAE-dextran (0.5 mglml) containing 1 ,ug of reporter recombinant, 5 ,ug of an oncogene expression vector, and 1 ,ug of the internal control plasmid ppCBX2. Cells were washed and incubated for 3 h with 100 ,uM cloroquine phosphate in culture medium supplemented with 10% fetal calf serum (FCS). After being washed, cells were incubated in low-serum (0.5% FCS) culture medium until they were harvested 36 h later. TPA (300 ng/ml) was added 12 h posttransfection for 24 (6 ,uM) was added, where indicated (see Fig. 5 ), during the 20-h period prior to the harvesting of the cells. Transfections were repeated at least twice for each experimental point, and variability did not exceed 20%.
Si nuclease analysis. The structure of oncogene expression vectors was described previously (38) . The probe used in quantitative S1 mapping was an 80-mer oligonucleotide containing 59 nucleotides complementary to the -9 to +50 region of the rabbit P-globin gene and 21 noncomplementary nucleotides. The first 50 nucleotides of the ,-globin mRNA transcribed from the reporter recombinants hybridize specifically with this probe, giving, after digestion with Si nuclease, a 50-base band. The same probe also hybridizes with nucleotides -9 to +50 of the RNA transcribed from the control recombinant p,CBX2 (which contains the conalbumin promoter), giving a 59-base band. An excess of this probe (105 cpm; 10 fmol) was hybridized overnight at 65°C with total RNA (up to 50 p.g) in 10 pL. of 0.04 M piperazine-N,N'-bis(2-ethanesulfonic acid) (PIPES, pH 7)-0.4 M Fig. 3 . The pGl transcription level is considered equal to 1. b TPA was added at a concentration of 300 ng/ml during the 12-to 36-h posttransfection period.
NaCl-1 mM EDTA, and Si mapping was performed as previously described (38) . The specific bands were quantitated by scanning adequately exposed autoradiograms.
RESULTS
In NIH 3T3 cells, the CArG box is necessary and sufficient to mediate transcription activation by the Ha-ras oncogene.
Transcriptional activation by ras of the human c-fos promoter was investigated by using recombinants containing wild-type and mutated elements (from nucleotides -317 to -288; Fig. 1A ) in the expression vector pGl (Fig. 1B) . Mutations that abolish the binding of AP1 (Ml [1] ), SRF (M2 [29] ), and p62TCF (M3 [29] ) were introduced individually or in pairs (M2-3, M1-3, and M1-2). These recombinants were transiently transfected in NIH 3T3 cells, together with control or ras expression vectors. Basal and ras-induced transcription was measured by Si nuclease mapping (Fig. 2) . The wild type is strongly induced by ras expression (Fig. 2,  WT) . Mutations in the FAP site and in the outer arm, either individually (Ml and M3, respectively) or in combination (M1-3), do not affect activation by ras. In contrast, mutations in the CArG box (M2, M2-3, and M1-2) completely abolish ras induction. Indeed, the CArG box alone is sufficient to mediate transcription activation by ras (Fig. 2,  M1-3) .
In HeLa cells, sequences besides the CArG box are critical for transcription activation by the Ha-ras oncogene. In HeLa cells, transcription of the wild-type recombinant is strongly induced by Ha-ras expression (Fig. 3, WT) . However, neither the CArG box nor the other motifs alone respond to ras expression ( Fig. 3 ; M2-3, M1-3, and M1-2). The outer arm is essential for the activation of transcription by ras, in combination either with the CArG box or with the FAP site (Fig. 3, Ml and M2, respectively) . However, it is not sufficient (Fig. 3, M3) , showing that there is cooperation (38) . Incubation with cadmium began at 16 h posttransfection and ended with the harvesting of the cells. between these sequences. These experiments demonstrate different and cell-specific requirements for the activation of this c-fos minimal promoter by the ras oncogene.
Several other nonnuclear oncoproteins and the tumor promoter TPA activate transcription through the outer arm and the CArG box. It has been previously shown that the same oncogenes can activate the oncogene-responsive sequences of the polyomavirus enhancer and the collagenase gene promoter (11, 37) . In the LMTK-fibroblast cell line, transcription of Ml, which contains the outer arm and the CArG box, is also induced by the expression of these oncogenes (Ha-ras, v-src, polyomavirus middle-T antigen gene, v-mos, and v-raf) and TPA (Table 1) . Both the outer arm and the CArG box are absolutely required for activation (M1-3 and M1-2 in Table 1 ). Similarly, in HeLa cells both sequences are necessary (Table 1 ). These two elements of thefos promoter are different from those of the collagenase gene promoter and the polyomavirus enhancer, but they nevertheless respond to the same oncogenes.
The SRF is a cell line-specific transcriptional activator. We expressed SRF in vivo from a pSG5-based (9) (Fig. 4A, WT) . Only mutations in the CArG box abolish activation by SRF ( Fig. 4A; M2, M2-3, and M1-2) . In contrast, in HeLa cells (Fig. 4B) , SRF does not activate any of the reporters, even though different quantities (from 0.25 to 20 ,ug) of SRF expression vector were used (data not shown). The pSG5 expression vector is functional in HeLa cells, as shown by the results for pSG5-src (v-src) in Table 1 and by other work from this laboratory. Thus, SRF is a cell line-specific transcription factor.
Intracellular levels of Fos contribute to cell line-specific regulation of the oncogene-responsive sequences of the c-fos promoter. Synthesis of the Fos protein can be induced by cadmium in NIH MT-FOS cells, which contain an exogenously added c-fos gene under the control of the human methallothionein II A gene promoter (39) . NIH MT-FOS cells were transiently transfected with the fos reporter recombinants and expression vectors for ras and SRF. In noninduced cells, both ras and SRF activated transcription of Ml (Fig. 5 , Ml -), as they did in the parental NIH 3T3 cells. Fos synthesis diminished activation by ras and completely abolished stimulation by SRF (Fig. 5 , Ml +). The CArG box was sufficient for a low level of activation by ras but not by SRF (Fig. 5, M1-3 -) . In noninduced conditions, MT-FOS cells have a behavior intermediate between that of NIH 3T3 cells and that of induced MT-FOS cells (Fig. 2, 4A , and 5), most probably because of increased basal Fos production in these cells (39) . In contrast, after Fos induction, transcription was activated neither by ras nor by SRF (Fig. 5, M1-3 +) . The outer arm alone does not respond to ras or SRF expression (Fig. 5, M1-2) . These experiments show that when the intracellular level of Fos is high, the CArG box alone does not respond to ras or SRF and that both the CArG box and the outer arm are necessary, suggesting that constitutive Fos protein levels could determine the cell-specific response of these oncogene-responsive sequences of the c-fos promoter.
DISCUSSION
The c-fos promoter contains an ORU encompassing the CArG box, the outer arm of the SRE, and the FAP site. Although stimulation of the SRE by serum has been extensively studied, much less is known about its response to oncogenes. We show here that three contiguous regions of the c-fos human promoter participate in the response to the oncoproteins Ha-ras, v-src, v-mos, polyomavirus middle-T antigen, and v-raf and to the tumor promoter TPA. These regions are the CArG box, the outer arm of the SRE, and the FAP site (the latter was tested with ras only). We demonstrate that the outer arm cooperates with either the CArG box or the FAP site. We have previously shown (11, 37) that binding sites for different factors that are separated by short distances can cooperate in the response to oncogene expression. We have called this type of functional arrangement an oncogene-responsive unit (ORU) (12) . ORUs exists in the polyomavirus enhancer and in the human collagenase promoter (11, 37 (14) . Regulation through the outer arm plus FAP is not described in this model. them, suggesting that they are the nuclear targets of a common signaling pathway.
The c-fos ORU is regulated in a cell-specific manner. In NIH 3T3 cells, the CArG box is necessary and sufficient to mediate transcription activation by ras. In (21) . We show that it also activates transcription through the CArG box in NIH 3T3 but not in HeLa cells. This cell-specific regulation resembles that observed for ras. ras and SRF activate through the CArG box alone in NIH 3T3 cells, suggesting that SRF is one of the mediators of the transcriptional response to ras expression. This activation may be mediated by caseinkinase II, a component of the mitogenic signaling pathway that phosphorylates SRF and enhances its DNA binding activity (20) .
Different levels of the Fos oncoprotein contribute to the cell-specific activity of the c-fos promoter ORU. The level of Fos protein in the cell seems to determine the response to ras and SRF. With low levels of Fos, SRF can activate transcription, whereas with high levels SRF is inactive. The CArG box is sufficient to mediate a response to ras before Fos induction in NIH MT-FOS cells. In contrast, in induced cells, both the CArG box and the outer arm are required. Strikingly, this resembles the situation in HeLa cells, suggesting that the Fos protein itself could be a major determinant of cell-specific regulation of the c-fos promoter ORU.
How is the c-fos ORU regulated in a cell-specific manner?
We propose a model to explain cell-specific regulation of the c-fos promoter ORU, taking into account our results and those published by others (Fig. 6) . In NIH 3T3 cells in the basal state, both transcription from thefos promoter and Fos protein levels are low (4), and presumably expression of p62TCF protein is also low (which would explain the absence of an effect caused by mutating the outer arm). ras expression could increase SRF activity and transcription of thefos promoter through the CArG box. Consequently, Fos protein synthesis would repress its own promoter.
We presume that in HeLa cells, both the Fos protein and p62TCF are expressed at higher levels than in NIH 3T3 cells (from both the analogy with MT-FOS cells and the negative effects of mutating the outer arm). ras activation of p62TCF may help SRF overcome repression by Fos, whereas transfected SRF alone is not sufficient to activate transcription (our experiments). For Saccharomyces cerevisiae, an analogous regulation has been described in which MCM1, which binds to a CArG box, interacts alternatively with a coactivator or a corepressor (13, 16, 22) . High p62TCF activity could help to maintain a high basal level of Fos despite autorepression. In this model, p62TCF is an important determinant of intracellular Fos levels and thus could play a critical role in transformation. It is noteworthy that the outer arm is absent in several nononcogenes that have CArG boxes in their promoters (2, 3) , suggesting that this sequence has an important role.
